Shamir Capital v. Enlivex Therapeutics Ltd.: Complaint

Complaint alleging securities fraud in S.H.N. Financial Investments Ltd., d.b.a. Shamir Capital, of Israel v. Enlivex Therapeutics Ltd., of Israel, at the U. S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 17

Date: May 13, 2020

Defendants/Respondents: Enlivex Therapeutics Ltd.

Plaintiffs/Applicants: S.H.N. Financial Investments Ltd.

Case Number: Xx Xx Xx

Topic: Investment

Allegation: Fraud

Plaintiffs/Applicants Attorneys: Feuerstein Kulick, David Feuerstein

Topics

Keywords

Enlivex Therapeutics Ltd. S.H.N. Financial Investments Ltd. Shamir Capital

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.